VCM
CLB icon

Vigilant Capital Management’s Core Laboratories CLB Stock Holding History

Vigilant Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-200
Closed -$23K – 277
2017
Q1 		$23K Hold
200
– – ﹤0.01% 211
2016
Q4 		$24K Buy
+200
New +$22.1K ﹤0.01% 209
2015
Q2 		– Sell
-187
Closed -$20K – 281
2015
Q1 		$20K Hold
187
– – ﹤0.01% 220
2014
Q4 		$23K Hold
187
– – ﹤0.01% 230
2014
Q3 		$27K Buy
+187
New +$28.9K 0.01% 198

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vigilant Capital Management's CLB Position: Q2 2017 in Review

Vigilant Capital Management sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 200 shares — an estimated $23K sold.

Vigilant Capital Management first reported a position in CLB in Q3 2014 and held it in 5 quarters. The position peaked at $27K in Q3 2014. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • Vigilant Capital Management reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
  • Vigilant Capital Management sold 200 Core Laboratories shares in Q2 2017, an estimated $23K.
  • Vigilant Capital Management first reported a position in Core Laboratories in Q3 2014 and held it in 5 quarters.
  • Vigilant Capital Management's Core Laboratories position peaked at $27K in Q3 2014.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on Vigilant Capital Management's 13F filing for Q2 2017, filed 14 Jul 2017.